The pharmaceutical industry policy in the second half of 2012 will be issued densely
Release time: 2012-05-16 & nbsp & nbsp & nbsp Source:
In the second half of 2012，Some pharmaceutical industry policies will be introduced densely。Where，Full version of "Basic Medicine Catalog" is expected to be introduced in July-August this year，"Investigation and Monitoring of Reinforcement Factory Price" will be implemented Stake Sports Bettingstake online sports bettingon September 1，The next batch of special plans for the Development of General Famous Famous Chemical Pharmaceuticals and "Special of the Development of Biomedical Engineering Products" will also be released。
Guo Fanli, a researcher at the pharmaceutical industry in China Investment Consultant Pharmaceutical Industry，Looking at these upcoming medical policies，The more obvious feature is that "drug prices" will become the focus of the follow -up。At present, two types of drug prices in my country are divided into two types of national pricing and independent pricing of enterprises。In accordance with the Regulations of the Interim Measures for the Management of Drug Price，Pharmaceuticals in the drug directory of government management prices，Allows drug manufacturers and operators without breaking the factory price stipulated by the state、Wholesale price、On the premise of retail price，Determine the specific price according to market conditions。
and the reason why drug prices are delayed and unable to control，The main reason is that the drugs produced by pharmaceutical companies My stake betting appstake betting appare available in the premium chain of patients involved in production、Supply、Sales and other links。Among them, starting from production，There is a purchase difference between production costs and suppliers; secondly, during the transportation process of drug transportation，There is also a cost difference; the third bidding process involves the cost of bidding; there is a large price difference between the fourth pharmaceutical sales and the factory price，This also makes the new medical reform "alleviate the people's expensive medical treatment".。
Guo Fanli pointed out，The supply and demand of Chinese pharmaceutical companies and public hospitals and other medical institutions is mostly，Demand，Public hospitals account for the majority，Other medical institutions account for a minority。Supply，Pharmaceutical companies supply the overall smooth supply。Current，my country has not yet established a drug market operation mechanism，The disorderly competition in the drug market is more intense。supply and demand has a more obvious impact on my country's drug market，Under this My stake betting appstake online sports bettingaction，Government -dominated drug market，helps to promote the drug market to intensify、scale、High concentration direction development。
Guo Fanli said at the same time，The types of pharmaceuticals in my country's pharmaceutical industry are concentrated in anesthesia drugs、Psychiatric drugs、Medical toxic drugs、Radioxids and drug drugs、Prescription drugs and non -prescription medicines。my country released the "Administrative Measures for the National Basic Drug Catalog" in 2009，The category of Chinese medicine items in the basic drug system basically covers local pharmaceutical companies。The impact of cancellation of drug bonuses on the supply of drugs in the pharmaceutical industry is two major aspects。First of all, it is conducive to breaking the interest chain of pharmaceutical supply in the pharmaceutical industry，The second is conducive to accelerating the pace of construction of the supply talent team in the pharmaceutical industry。
Guo Fanli, a researcher at the pharmaceutical industry in China Investment Consultant Pharmaceutical Industry，Looking at these upcoming medical policies，The more obvious feature is that "drug prices" will become the focus of the follow -up。At present, two types of drug prices in my country are divided into two types of national pricing and independent pricing of enterprises。In accordance with the Regulations of the Interim Measures for the Management of Drug Price，Pharmaceuticals in the drug directory of government management prices，Allows drug manufacturers and operators without breaking the factory price stipulated by the state、Wholesale price、On the premise of retail price，Determine the specific price according to market conditions。
and the reason why drug prices are delayed and unable to control，The main reason is that the drugs produced by pharmaceutical companies My stake betting appstake betting appare available in the premium chain of patients involved in production、Supply、Sales and other links。Among them, starting from production，There is a purchase difference between production costs and suppliers; secondly, during the transportation process of drug transportation，There is also a cost difference; the third bidding process involves the cost of bidding; there is a large price difference between the fourth pharmaceutical sales and the factory price，This also makes the new medical reform "alleviate the people's expensive medical treatment".。
Guo Fanli pointed out，The supply and demand of Chinese pharmaceutical companies and public hospitals and other medical institutions is mostly，Demand，Public hospitals account for the majority，Other medical institutions account for a minority。Supply，Pharmaceutical companies supply the overall smooth supply。Current，my country has not yet established a drug market operation mechanism，The disorderly competition in the drug market is more intense。supply and demand has a more obvious impact on my country's drug market，Under this My stake betting appstake online sports bettingaction，Government -dominated drug market，helps to promote the drug market to intensify、scale、High concentration direction development。
Guo Fanli said at the same time，The types of pharmaceuticals in my country's pharmaceutical industry are concentrated in anesthesia drugs、Psychiatric drugs、Medical toxic drugs、Radioxids and drug drugs、Prescription drugs and non -prescription medicines。my country released the "Administrative Measures for the National Basic Drug Catalog" in 2009，The category of Chinese medicine items in the basic drug system basically covers local pharmaceutical companies。The impact of cancellation of drug bonuses on the supply of drugs in the pharmaceutical industry is two major aspects。First of all, it is conducive to breaking the interest chain of pharmaceutical supply in the pharmaceutical industry，The second is conducive to accelerating the pace of construction of the supply talent team in the pharmaceutical industry。
